Patents by Inventor Dahye Kang

Dahye Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240208898
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts and stereoisomers thereof that are suitable for diagnosis and the treatment of diseases and disorders characterized by, associate with or which exhibit tissue hypoxia, such as, for example, solid tumors. Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds.
    Type: Application
    Filed: March 24, 2022
    Publication date: June 27, 2024
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Justin Kim, Dahye Kang, Sheldon T. Cheung
  • Publication number: 20240165259
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts and stereoisomers thereof that are suitable for cellular labeling or the treatment of cancer. Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds.
    Type: Application
    Filed: April 4, 2022
    Publication date: May 23, 2024
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Justin Kim, Dahye Kang